Gridiron BioNutrients™ announces confirmation of ticker symbol and name change.
SPOKANE, Wash., Dec. 19, 2017 /PRNewswire/ — Gridiron BioNutrients™ (OTC: GMVP) (the “Company” or “Gridiron”) formerly MyCloudz, Inc., a nutraceutical innovator specializing in Cannabidiol (“CBD”) health and wellness products to the individual, is pleased to announce the confirmation of the Company’s name change to Gridiron BioNutrients, Inc. and ticker symbol change to GMVP effective December 19, 2017.
The Company’s common shares are expected to begin trading on the OTC Pink “The Open Market” (Venue –OTC Link) under the symbol “GMVP.” The new CUSIP will be 39809D102. “This is an important step as we continue to progress in the development of our brand, which includes Gridiron MVP™ and Gridiron CBD H2O Probiotics™ each endorsed under Pro Football Legends, the commercial marketing arm of the NFL Alumni. We estimate our branding efforts for our full line of CBD products will be completed by the end of January 2018,” stated Tim Orr, President of Gridiron.
About Gridiron BioNutrients™
Gridiron is focused on the development and commercialization of high quality innovative CBD products within the health and wellness marketplace; Gridiron strives to formulate and design products that maximize the human body’s potential to enable individuals to heal faster, train longer and recover quicker.
Safe Harbor for Forward-Looking Statements: Except for historical information contained herein, statements in this release may be forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words such as “anticipate,” “believe,” “estimate,” “expect,” “intend” and similar expressions, as they relate to Gridiron BioNutrients™ (the “Company”) or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the Company’s business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in the Company’s filings with the Securities and Exchange Commission. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as (i) the development and protection of our brands and other intellectual property, (ii) the need to raise capital to meet business requirements, (iii) significant fluctuations in marketing expenses, (iv) the ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of our products and services, (v) the Company’s ability to conduct the business if there are changes in laws, regulations, or government policies related to cannabis, (vi) management’s ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and (vii) other information that may be detailed from time to time in the Company’s filings with the United States Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.